why choose us

First received: September 21, 2023

Clinical Trial: Renal Cell Arrest and Damage Biomarkers in Progression and Outcome of Septic AKI

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: AKI - Acute Kidney Injury

Study Type: INTERVENTIONAL


Official Title: Role of Renal Cell Arrest and Damage Biomarkers in Progression and Outcome of Sepsis Associated AKI

Brief Summary: The aim of the current study is to assess the predictive value of renal cell arrest biomarkers (urinary TIMP2 and IGFBP7), renal damage biomarkers (urinary KIM-1) and microscopic examination of urinary sediment in progression and outcome of sepsis associated AKI.

Read more